BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20304286)

  • 21. Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma.
    Nehls O; Okech T; Hsieh CJ; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Porschen R; Gregor M; Klump B
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):85-91. PubMed ID: 15629598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
    Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
    J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
    Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma.
    Palme CE; O'Brien CJ; Veness MJ; McNeil EB; Bron LP; Morgan GJ
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):750-3. PubMed ID: 12874077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
    Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of bax, cytochrome C, and caspase-8 protein expression in primary osteosarcoma.
    Kaseta MK; Gomatos IP; Khaldi L; Tzagarakis GP; Alevizos L; Themistocleous GS; Leandros E; Soucacos PN
    Hybridoma (Larchmt); 2007 Dec; 26(6):355-62. PubMed ID: 18158779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
    Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
    In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic strategies for the treatment of parotid gland malignancies].
    Magnano M; Gervasio CF; Cravero L; Lerda W; Orecchia R; Ragona R
    Acta Otorhinolaryngol Ital; 1998 Jun; 18(3):164-71. PubMed ID: 9926450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
    Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
    Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients.
    Genetzakis M; Gomatos IP; Georgiou AN; Giotakis J; Manolopoulos L; Papadimitriou K; Chra H; Leandros E; Tsigris C; Ferekidis EA
    Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):417-24. PubMed ID: 18584190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS; Waelchli L; Bründler MA
    Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.
    Rubio J; Ramos D; López-Guerrero JA; Iborra I; Collado A; Solsona E; Almenar S; Llombart-Bosch A
    Eur Urol; 2005 Nov; 48(5):745-51. PubMed ID: 16139948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.